Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Revenue Increased 17% Quarter over QuarterOperating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ETLITTLETON, Colo., ...